A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep28779.pdf
Reference27 articles.
1. Chen, C. J. et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. Jama 295, 65–73, doi: 10.1001/jama.295.1.65 (2006).
2. Martin, P. et al. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 13, 2071–2087 e2016, doi: 10.1016/j.cgh.2015.07.007 (2015).
3. Liaw, Y. F. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy. Antiviral therapy 11, 669–679 (2006).
4. Chang, T. T. et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 52, 886–893, doi: 10.1002/hep.23785 (2010).
5. Lai, C. L. et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. The New England journal of medicine 354, 1011–1020, doi: 10.1056/NEJMoa051287 (2006).
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 2′-Fluoro-6′-methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti-HBV agent, active against drug-resistant HBV mutants;Medicinal Research Reviews;2018-02-06
2. A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study;British Journal of Clinical Pharmacology;2017-06-18
3. Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment;Scientific Reports;2016-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3